Occupational Therapists in Newberg, OR Accepting Medicare
10 Occupational Therapists found. Showing 1 - 10
 Ms. Jeanne Ellen Haislip, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Foothills Dr, Newberg, OR 97132 Phone: 503-554-0767 |
Marla Bisceglie, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Fulton St, Newberg, OR 97132 Phone: 503-538-2108 |
Valery Brisbane Sampson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Villa Rd, Newberg, OR 97132 Phone: 503-537-3546 |
Kara Fenton, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Providence Dr, Newberg, OR 97132 Phone: 503-537-1863 |
Kyla Laraway, MS, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 310 Villa Rd, Newberg, OR 97132 Phone: 503-537-3546 |
Jessica Smith, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 700 Deborah Rd Ste 190, Newberg, OR 97132 Phone: 503-537-7070 |
Luvonne T. Votaw, BSOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 N Everest Rd, Newberg, OR 97132 Phone: 503-538-8952 Fax: 503-537-2027 |
Leanne Klein Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 310 Villa Rd Ste 101, Newberg, OR 97132 Phone: 503-537-3546 |
Carla Ledva Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 E Fulton St, Newberg, OR 97132 Phone: 503-538-2108 |
Rachel Graves, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Providence Drive, Suite 220, Newberg, OR 97132 Phone: 503-537-1863 |
News Archive
Academia-Industry Partnership Leads Innovative New Approach to Alternative Dental Filling Material
A medical device case study: UCL researchers and dental materials manufacturer collaborate to speed up the development of a new dental filling material for children.
Pfizer reports positive results from rLP2086 Phase 2 study for invasive meningococcal disease
Pfizer Inc. announced today the results from two Phase 2 studies of bivalent rLP2086, Pfizer's recombinant vaccine candidate, currently under development for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 to 25 year olds.
Optimer prices underwritten public offering of common stock
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
Azoi announces launch of innovative mobile health monitoring device
Azoi, a technology company dedicated to helping people improve their lives, today announced Wello – an innovative health monitoring device embedded within a mobile phone case. With just a few powerful sensors, Wello fits onto a smartphone and measures a number of key vitals including blood pressure, electrocardiography (ECG), heart rate, blood oxygen, temperature, lung functions and more – with a high level of accuracy. Fast and easy-to-use, Wello empowers people to track key data, improve awareness of their body's state, and make more informed lifestyle choices.
› Verified 4 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Optometrists
Occupational Therapists
Podiatrists
Audiologists